Personal Wealth Partners Eli Lilly & CO Transaction History

Personal Wealth Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $105,260 - $129,537	-475 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $85,761 - $110,931	475 New	475 $109,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $56,548 - $69,991	-475 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$110.79 - $129.32 $52,625 - $61,427	475 New	475 $53,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Personal Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Personal Wealth Partners with notifications on news.